TANG CAPITAL MANAGEMENT LLC Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$224.4B
Holdings
12
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (12 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRTXHERON THERAPEUTICS INC | 6,197,198 | $111.9B | 49.84% | |
| 2 | —LA JOLLA PHARMACEUTICAL CO | 3,052,130 | $48.8B | 21.76% | |
| 3 | —IGNYTA INC | 3,972,800 | $21.5B | 9.59% | |
| 4 | OPK 3 02/01/33 AIOPKO HEALTH INC | 14,000,000 | $19.8B | 8.80% | |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 90,215 | $7.0B | 3.13% | |
| 6 | BABAALIBABA GROUP HOLDING LIMITED | 60,000 | $4.8B | 2.13% | |
| 7 | —MERRIMACK PHARMACEUTICALS INC | 3,500,000 | $4.0B | 1.77% | |
| 8 | NKTREURNEKTAR THERAPEUTICS | 260,000 | $3.7B | 1.65% | |
| 9 | BCRXBIOCRYST PHARMACEUTICALS INC | 430,000 | $1.2B | 0.54% | |
| 10 | —LIPOCINE INC | 260,000 | $790.0M | 0.35% | |
| 11 | —ATYR PHARMA INC | 279,425 | $777.0M | 0.35% | |
| 12 | —CELLDEX THERAPUETICS INC | 50,000 | $220.0M | 0.10% |